162 related articles for article (PubMed ID: 6098743)
1. [Clinical evaluation of cefmenoxime in internal medicine, with special reference to infections associated with hematological disorders].
Uchida T; Matsuda S; Kimura H; Satoh T; Ishibashi T; Kokubun K; Umezu H; Horikawa A; Saitoh T; Sakauchi Y
Jpn J Antibiot; 1984 Dec; 37(12):2506-18. PubMed ID: 6098743
[TBL] [Abstract][Full Text] [Related]
2. [Clinical evaluation of cefmenoxime in internal medicine, with special reference to infection associated with hematological disorders].
Kawamura S; Sakata Y; Chiba Y; Yoshida Y; Kanazawa T; Kawazu S; Tsuge M; Tanabe K; Nara H; Aizawa M
Jpn J Antibiot; 1986 May; 39(5):1250-8. PubMed ID: 3463775
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of a combination therapy using cefmenoxime and cefsulodin on infections complicated by hematological disorders. Tohkai Research Group on Infections in Hematopoietic Disorders].
Minami N; Uno N; Shirakawa S; Ohno R; Okumura M; Yamamoto M; Mitomo Y; Hirano M; Shimizu S; Yamada K
Jpn J Antibiot; 1986 Mar; 39(3):713-20. PubMed ID: 3488423
[TBL] [Abstract][Full Text] [Related]
4. [Clinical evaluation of cefmenoxime in chronic complicated urinary tract infection].
Ashiki A; Sudo Y; Suzuki T; Yamato K; Tsukui A; Hamada W; Kusumi Y
Jpn J Antibiot; 1985 Jan; 38(1):49-61. PubMed ID: 3857363
[TBL] [Abstract][Full Text] [Related]
5. [Clinical evaluation of cefotiam in internal medicine, with special reference to infectious disease associated with hematological disorders (author's transl)].
Uchida T; Matsuda S; Tanaka T; Muroi S; Kimura H; Satoh T; Yui T; Satoh S; Fujino A; Mita M; Yamada Z; Kariyone S; Yoshida H; Kikuta T; Miura N; Itoh K; Ikeda K; Nemoto T; Hiraguri M; Sanbe M; Takezawa M; Nakamura Y; Satoh Y; Funayama S; Igarashi T; Ogiu A; Maseki N; Komatsu M
Jpn J Antibiot; 1981 Aug; 34(8):1148-57. PubMed ID: 6275142
[TBL] [Abstract][Full Text] [Related]
6. [Clinical investigation of the therapeutic effects of cefmenoxime in the treatment of infections complicated by hematological diseases].
Kozuru M; Kurata T; Uike N; Niho Y; Shibuya T; Otsuka T; Yamano Y; Hirota Y; Nishimura J; Katsuno M
Jpn J Antibiot; 1986 Mar; 39(3):701-12. PubMed ID: 3488422
[TBL] [Abstract][Full Text] [Related]
7. [Clinical experience with cefmenoxime (CMX) in complicated urinary tract infections].
Minami Y; Kanda S; Matsuo R; Sakai H; Kamemoto H; Hisamatsu A; Maruta N; Johdai A; Shimomae H; Watanabe Y
Hinyokika Kiyo; 1985 Jun; 31(6):1077-84. PubMed ID: 3864365
[TBL] [Abstract][Full Text] [Related]
8. [Clinical studies on cefmenoxime in the pediatric field].
Okamoto K; Shino K; Fuke H; Watanabe K; Ozaki H
Jpn J Antibiot; 1982 Nov; 35(11):2545-54. PubMed ID: 6302336
[TBL] [Abstract][Full Text] [Related]
9. [Clinical evaluation of cefmenoxime in the pediatric infections].
Meguro H; Ozawa S; Togo T; Hiraiwa M; Kim B; Fujii R
Jpn J Antibiot; 1982 Oct; 35(10):2405-13. PubMed ID: 6306292
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of cefotiam in internal medicine].
Kawamura S; Sakata Y; Chiba Y; Yoshida Y; Aizawa M; Nara H; Yanagiya S; Fukushi K; Ohmi T; Okamoto K; Komatsu Y; Haneda Y; Tanabe K; Segawa M; Yamagata A; Kawatsu S
Jpn J Antibiot; 1982 May; 35(5):1136-44. PubMed ID: 6290697
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic effects of cefmenoxime in the treatment of various infections on infants and children].
Kurashige T; Wakiguchi H; Kitamura I; Ozaki H; Nishibayashi Y; Hamawaki M
Jpn J Antibiot; 1982 Nov; 35(11):2579-88. PubMed ID: 6302339
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of cefmenoxime versus cefoxitin in serious infections.
Bechard DL; Hawkins SH; Sutherland SC
Am J Med; 1984 Dec; 77(6A):13-6. PubMed ID: 6097117
[TBL] [Abstract][Full Text] [Related]
13. [Effect of cefotaxime in the treatment of infections associated with hematologic diseases].
Kaneko H; Masaki T; Yamaguchi R; Takahashi N; Umeda M; Shirai T
Jpn J Antibiot; 1983 Sep; 36(9):2502-14. PubMed ID: 6317914
[TBL] [Abstract][Full Text] [Related]
14. [Clinical evaluation of cefmenoxime and cefsulodin in chronic complicated urinary tract infections].
Shiraiwa Y; Yamaguchi O; Ito K; Kuma Y; Hozumi S; Kumakawa K; Ishiwata H; Arai M; Hirai T; Kumagai I
Jpn J Antibiot; 1986 Oct; 39(10):2661-74. PubMed ID: 3468273
[TBL] [Abstract][Full Text] [Related]
15. [Studies on the intravenous administration of cefmenoxime in pediatric field].
Nakazawa S; Sato H; Niino K; Hirama Y; Narita A; Nakazawa S; Chikaoka H; Oka S
Jpn J Antibiot; 1982 Oct; 35(10):2393-404. PubMed ID: 6306291
[No Abstract] [Full Text] [Related]
16. [Clinical evaluation of cefmenoxime (CMX) for complicated urinary tract infection].
Tsuchida S; Sasaki S; Takada H; Miyagata S; Sato S; Shimizu S; Sakamoto F; Kizu N
Hinyokika Kiyo; 1985 Feb; 31(2):365-74. PubMed ID: 3859998
[TBL] [Abstract][Full Text] [Related]
17. [Laboratory and clinical studies on cefmenoxime in respiratory tract infections].
Ida S; Nishioka K; Takishima T; Kudo K; Sakamoto M; Inoue C; Shimanuki K; Fujimoto R; Miura M; Takahashi M
Jpn J Antibiot; 1986 Nov; 39(11):2869-76. PubMed ID: 3469421
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of cefmenoxime in severe infections in leukemia and related disorders].
Tsuda S; Nishida K; Maekawa T; Abe T; Takino T; Fujii H; Taniwaki M; Yashige H; Horiike S; Yokota S
Jpn J Antibiot; 1986 Oct; 39(10):2651-60. PubMed ID: 3468272
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies with cefmenoxime in the field of pediatrics].
Takimoto M; Yoshioka H; Maruyama S; Sanae N; Nagamatsu I
Jpn J Antibiot; 1982 Oct; 35(10):2379-83. PubMed ID: 6306289
[TBL] [Abstract][Full Text] [Related]
20. [Basic and clinical studies on cefmenoxime in pediatric field].
Iwata S; Iwasaki Y; Kanemitsu T; Akita H; Hotta M; Yamashita N; Nanri S; Wakabayashi R; Kojima Y; Sunakawa K; Osano M; Ichihashi Y; Tachibana Y; Takahashi H; Kori T
Jpn J Antibiot; 1982 Oct; 35(10):2440-9. PubMed ID: 6306295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
